Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

BACKGROUND: Since direct oral anticoagulants (DOACs) have been introduced for treatment and prevention of thromboembolic diseases, patients on vitamin K antagonists (VKA) have to decide whether to remain on VKA or switch to DOAC. The goal of this study was to evaluate treatment satisfaction, prefere...

Descripción completa

Detalles Bibliográficos
Autores principales: Toorop, Myrthe M. A., van Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., van der Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318134/
https://www.ncbi.nlm.nih.gov/pubmed/32170987
http://dx.doi.org/10.1111/jth.14793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318134/
https://www.ncbi.nlm.nih.gov/pubmed/32170987
http://dx.doi.org/10.1111/jth.14793

Ejemplares similares